Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript

Aug 11, 2020 / 04:00PM GMT
Release Date Price: $81.62 (-5.00%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Great. Welcome, day 1 of the UBS Genomics 2.0 and Medtech Innovations Conference. This is Dan Brennan. I cover tools, diagnostics and pharma services.

I'm really pleased to be joined with me here at our 12:00 session with Helmy Eltoukhy, who I'm sure everyone knows very well, CEO of Guardant Health. So Helmy, thank you very much for participating.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Yes. Thank you, Dan, for having me.

Questions & Answers

Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

That's terrific. Great. So obviously, a lot of great things to talk about. I got a lot of questions, which I'll try, I won't be able to get to all of them. So hopefully, I'll jump around and get the key points. Feel free for those on the phone to shoot me your question, I'll try to get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot